Idorsia is advancing the treatment of hypertension with new data at the 2024 American Heart Association Scientific Sessions
| MLSS Stock | USD 0.96 0.02 2.04% |
Slightly above 61% of Milestone Scientific's investor base is looking to short. The analysis of overall sentiment of trading Milestone Scientific stock suggests that many investors are alarmed at this time. Milestone Scientific's investing sentiment can be driven by a variety of factors including economic data, Milestone Scientific's earnings reports, geopolitical events, and overall market trends.
Milestone | Build AI portfolio with Milestone Stock |
Allschwil, Switzerland November 11, 2024 Idorsia Ltd today announced that new data on aprocitentan, the first-and-only dual endothelin...
Read at globenewswire.com
 |
Milestone Scientific Fundamental Analysis
We analyze Milestone Scientific's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Milestone Scientific using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Milestone Scientific based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
EBITDA
EBITDA Comparative Analysis
Milestone Scientific is currently under evaluation in ebitda category among its peers. EBITDA stands for earnings before interest, taxes, depreciation, and amortization. It is a measure of a company operating cash flow based on data from the company income statement and is a very good way to compare companies within industries or across different sectors. However, unlike Operating Cash Flow, EBITDA does not include the effects of changes in working capital.
Milestone Scientific Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Milestone Scientific stock to make a market-neutral strategy. Peer analysis of Milestone Scientific could also be used in its relative valuation, which is a method of valuing Milestone Scientific by comparing valuation metrics with similar companies.
Peers
Milestone Scientific Related Equities
| INFU | InfuSystems Holdings | 0.58 | ||||
| RVP | Retractable Technologies | 1.45 | ||||
| OCX | OncoCyte Corp | 2.10 | ||||
| PAVM | PAVmed | 4.62 | ||||
| SSKN | STRATA Skin | 7.78 |
Additional Tools for Milestone Stock Analysis
When running Milestone Scientific's price analysis, check to measure Milestone Scientific's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Milestone Scientific is operating at the current time. Most of Milestone Scientific's value examination focuses on studying past and present price action to predict the probability of Milestone Scientific's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Milestone Scientific's price. Additionally, you may evaluate how the addition of Milestone Scientific to your portfolios can decrease your overall portfolio volatility.